Dr. Ananda Chatterjee, MD

Dr. Chatterjee practices at Cedars-Sinai Medical Center in West Hollywood, California.

Dr. Chatterjee's NPI, 1376984021, was assigned on July 10, 2013. Dr. Chatterjee graduated from Ross University School of Medicine in 2011. Dr. Chatterjee holds California license C183981.

Dr. Chatterjee's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, West Hollywood, CA 90048 in Los Angeles County. The practice phone is (323) 866-8600.

Dr. Chatterjee's primary practice is Cedars-Sinai Medical Center in West Hollywood, California. The medical group on file is Cedars-Sinai Medical Group. Dmand AI also links Dr. Chatterjee to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chatterjee practices. Vendor and product names are available with a free account.

Family medicine is Dr. Chatterjee's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Dr. Chatterjee is board certified in family medicine by the American Board of Family Medicine. Dmand AI has Dr. Chatterjee's licenses on file in 5 states: California, Florida, Michigan, New York and Oregon.

CMS data shows 264 Medicare services from Dr. Chatterjee across 2 procedure codes in 2024, all of them office visits, for 125 Medicare patients. Medicare paid $25,363 for them. Every service was in an office.

CMS counts 125 Medicare patients who saw Dr. Chatterjee in 2024. The largest group is 65 to 74, with 75 patients. 75% of them have high cholesterol, and 62% have high blood pressure. 17% are also on Medicaid. Their average risk score is 0.99, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Chatterjee's median patient age at 46, with 74% women.

In 2024, Dr. Chatterjee wrote 188 Medicare Part D claims for 79 patients. 56% of them were for generic drugs. CMS names the drug for 125 of them, across 5 drugs with 11 or more claims each, at $74,036 in total drug cost. In 2022, CMS named 56 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Chatterjee for performance year 2024, reported as part of a group. Dr. Chatterjee accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chatterjee as offering telehealth.

Dmand AI links 8 papers to Dr. Chatterjee, published from 2013 to 2015. 2013 was the busiest year, with 3. The most frequent topics are Guideline Adherence.

Dmand AI links Dr. Chatterjee to 1 clinical trial. Conditions studied include Pharyngitis and Pharyngeal Diseases.

CMS Open Payments shows 6 general payments to Dr. Chatterjee from 5 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $243.

Dr. Chatterjee graduated from Ross University School of Medicine in 2011.

Dr. Chatterjee is in network with 7 carriers, including Blue Cross Blue Shield of Michigan, Highmark and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.